Left atrial appendage-flow velocity predicts cardioversion success in atrial fibrillation

Bahri Akdeniz1, Ozer Badak, Nezihi Bariş

  • 1Department of Cardiology, Dokuz Eylül University School of Medicine, Izmir, Turkey. bahri.akdeniz@deu.edu.tr

Insights

Left atrial appendage (LAA) flow velocity is a key predictor of successful electrical cardioversion in atrial fibrillation patients. Higher LAA flow velocity indicates a greater chance of restoring normal heart rhythm.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Electrical cardioversion aims to restore normal heart rhythm in atrial fibrillation patients.
  • Predicting cardioversion success using traditional methods is often limited.
  • The role of left atrial appendage (LAA) function in predicting outcomes is not well understood.

Purpose of the Study:

  • To investigate the predictive value of LAA function for electrical cardioversion success in atrial fibrillation.
  • To determine if LAA peak flow velocity, area, or ejection fraction can predict cardioversion outcomes.

Main Methods:

  • A prospective study involving 163 atrial fibrillation patients undergoing electrical cardioversion.
  • Transthoracic and transesophageal echocardiography (TEE) were used to assess LAA function before cardioversion.
  • LAA peak flow velocity, area, and ejection fraction were measured.

Main Results:

  • Cardioversion was successful in 133 patients and unsuccessful in 30.
  • Mean LAA peak emptying flow velocity was significantly higher in successful cardioversion cases (0.34 m/sec) compared to unsuccessful ones (0.27 m/sec).
  • LAA flow velocity > 0.28 m/sec was identified as an independent predictor of cardioversion success (OR=2.8, p=0.03).

Conclusions:

  • LAA flow velocity is a valuable independent predictor of electrical cardioversion success in atrial fibrillation.
  • LAA area and ejection fraction did not significantly predict cardioversion outcomes.
  • Measuring LAA flow velocity offers crucial information for patient selection and pre-cardioversion assessment.